Breiter Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.13M Hold
1,909
0.56% 52
2021
Q4
$1.27M Buy
1,909
+1
+0.1% +$624 0.62% 51
2021
Q3
$1.09M Buy
1,908
+1
+0.1% +$549 0.62% 52
2021
Q2
$962K Buy
+1,907
New +$900K 0.52% 57
2021
Q1
Sell
-1,865
Closed -$869K 117
2020
Q4
$869K Buy
1,865
+1
+0.1% +$469 0.6% 54
2020
Q3
$823K Buy
1,864
+1
+0.1% +$413 0.67% 50
2020
Q2
$675K Buy
1,863
+1
+0.1% +$335 0.63% 51
2020
Q1
$528K Buy
1,862
+1
+0.1% +$315 0.62% 56
2019
Q4
$605K Buy
1,861
+1
+0.1% +$303 0.66% 49
2019
Q3
$542K Buy
1,860
+1,111
+148% +$318K 0.71% 45
2019
Q2
$220K Buy
+749
New +$206K 0.29% 76

Other funds holding TMO

Breiter Capital Management's TMO Position: Q1 2022 in Review

Breiter Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2022 at 1,909 shares worth $1.13M. The position accounts for 0.56% of the portfolio, ranked #52.

Breiter Capital Management first reported a position in TMO in Q2 2019 and has held it in 11 quarters since. The position peaked at $1.27M in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Breiter Capital Management held 1,909 shares of Thermo Fisher Scientific worth $1.13M as of Q1 2022.
  • Breiter Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2022.
  • Thermo Fisher Scientific made up 0.56% of Breiter Capital Management's portfolio in Q1 2022, its #52 holding.
  • Breiter Capital Management first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 11 quarters since.
  • Breiter Capital Management's Thermo Fisher Scientific position peaked at $1.27M in Q4 2021.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Breiter Capital Management's 13F filing for Q1 2022, filed 11 May 2022.